(Q43752524)

26 November 2017

Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction (English)

1 reference

26 November 2017

myocardial infarction

1 reference

1 reference

1 reference

1 reference

Maria A Cavasin

1

1 reference

26 November 2017

Steadman S Sankey

2

1 reference

26 November 2017

Ai-Li Yu

3

1 reference

26 November 2017

Shreevidya Menon

4

1 reference

26 November 2017

Xiao-Ping Yang

5

1 reference

26 November 2017

language of work or name

1 reference

30 January 2003

1 reference

American Journal of Physiology Heart and Circulatory Physiology

26 November 2017

1 reference

26 November 2017

284

1 reference

26 November 2017

5

1 reference

26 November 2017

H1560-9

1 reference

Gender difference in autonomic and hemodynamic reactions to abrupt coronary occlusion.

26 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

CME Paper: Hormone Replacement Therapy for Prevention or Treatment of Atherosclerosis in Postmenopausal Women: Promises, Controversies, and Clinical Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Acute and Nongenomic Effects of Testosterone on Isolated and Perfused Rat Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Effects of oestrogen on the extracellular matrix in the endometrium of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Gonadal effects on plasma ACE activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Androgen receptors mediate hypertrophy in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Vascular reactivity is impaired in genetic females taking high-dose androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Mechanisms of estrogen action in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Estrogen modulates AT1 receptor gene expression in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Estrogen effects in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Serum sex hormone levels in postmenopausal women with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Relationship between serum sex hormones and coronary artery disease in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Androgen- and estrogen-dependent sex differences in host resistance to Strongyloides venezuelensis infection in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

Anabolic-androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.01087.2002

10.1152/AJPHEART.01087.2002

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference